Dear customers,
we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.
Fastest of its kind: New molecular biological test for the specific detection of EHEC bacteria
R-Biopharm (Darmstadt) has brought to the market the fastest assay currently available for the specific detection of enterohemorrhagic Escherichia coli (EHEC). With the new RIDA®GENE EHEC/EPEC [...]
3rd time in a row: Deloitte Sustained Excellence Award
Sustainable excellence in longterm and profitable growth awarded After awards in 2010 and 2013, R-Biopharm AG has won the Deloitte Sustained Excellence Award for the third time in a row [...]
Calprotectin predicts relaps after stopping TNFα treatment
Molander et al. investigated if concentrations of fecal calprotectin can be used for predicting relaps after stopping TNFα blocking therapy in patients with Ulcerative Colitis and Morbus Crohn.
Illness due to parasites: What you need to know about zoonoses
Zoonoses are infectious diseases which can be transmitted from animals to humans. More than 200 of these diseases are known. On World Zoonoses Day on July 6 we are presenting the most common [...]
Online seminar registration
15th Congress of ECCO
What’s new in the field of inflammatory bowel diseases (IBD)? Meet us at the ECCO Congress in Vienna and gain new scientific insights! The ECCO Congress, organized by the European Crohn’s and [...]